{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:09:04Z","timestamp":1767913744559,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T00:00:00Z","timestamp":1266364800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1245\/s10434-010-0950-2","type":"journal-article","created":{"date-parts":[[2010,2,16]],"date-time":"2010-02-16T12:42:41Z","timestamp":1266324161000},"page":"2119-2125","source":"Crossref","is-referenced-by-count":18,"title":["Incidental Breast Lesions Identified by 18F-Fluorodeoxyglucose-Positron Emission Tomography"],"prefix":"10.1245","volume":"17","author":[{"given":"Alice","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Schoder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Port","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,17]]},"reference":[{"key":"950_CR1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/snuc.2002.127291","volume":"32","author":"A Alavi","year":"2002","unstructured":"Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med. 2002;32:293\u2013321.","journal-title":"Semin Nucl Med."},{"key":"950_CR2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0001-2998(98)80038-X","volume":"28","author":"SM Bakheet","year":"1998","unstructured":"Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med. 1998;28:352\u20138.","journal-title":"Semin Nucl Med."},{"key":"950_CR3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(05)62225-8","volume":"350","author":"I Bicik","year":"1997","unstructured":"Bicik I, Bauerfeind P, Breitbach T, von Schulthess GK, Fried M. Inflammatory bowel disease activity measured by positron-emission tomography. Lancet. 1997;350:262.","journal-title":"Lancet."},{"key":"950_CR4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(94)90753-6","volume":"344","author":"P Lewis","year":"1994","unstructured":"Lewis P, Griffin S, Marsden P, Gee T, Nunan T, Malsey M. et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet. 1994;344:1265\u20136.","journal-title":"Lancet."},{"key":"950_CR5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s002590000277","volume":"27","author":"KD Stumpe","year":"2000","unstructured":"Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000;27:822\u201332.","journal-title":"Eur J Nucl Med."},{"key":"950_CR6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00003072-199612000-00021","volume":"21","author":"S Yasuda","year":"1996","unstructured":"Yasuda S, Shohtsu A, Ide M, Takagi S, Ogawa J, Mitomi T, et al. High fluorine-18 labeled deoxyglucose uptake in sarcoidosis. Clin Nucl Med. 1996;21:983\u20134.","journal-title":"Clin Nucl Med."},{"key":"950_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/snuc.2002.29278","volume":"32","author":"H Zhuang","year":"2002","unstructured":"Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47\u201359.","journal-title":"Semin Nucl Med."},{"key":"950_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1245\/s10434-006-9181-y","volume":"14","author":"C Are","year":"2007","unstructured":"Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR. FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol. 2007;14:239\u201347.","journal-title":"Ann Surg Oncol."},{"key":"950_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1245\/ASO.2006.05.042","volume":"13","author":"C Are","year":"2006","unstructured":"Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol. 2006;13:453\u201364.","journal-title":"Ann Surg Oncol."},{"key":"950_CR10","first-page":"1421","volume":"25","author":"YK Chen","year":"2005","unstructured":"Chen YK, Ding HJ, Chen KT, Chen YL, Liao AC, Shen YY, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res. 2005;25:1421\u20136.","journal-title":"Anticancer Res."},{"key":"950_CR11","first-page":"609","volume":"47","author":"JY Choi","year":"2006","unstructured":"Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET\/CT: clinical significance and improved characterization. J Nucl Med. 2006;47:609\u201315.","journal-title":"J Nucl Med."},{"key":"950_CR12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/000313480607200315","volume":"72","author":"QD Chu","year":"2006","unstructured":"Chu QD, Connor MS, Lilien DL, Johnson LW, Turnage RH, Li BD. Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. Am Surg. 2006;72:272\u20135.","journal-title":"Am Surg."},{"key":"950_CR13","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1210\/jc.2003-030465","volume":"88","author":"KW Kang","year":"2003","unstructured":"Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, Lee IG, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab. 2003;88:4100\u20134.","journal-title":"J Clin Endocrinol Metab."},{"key":"950_CR14","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/01.MLG.0000163098.01398.79","volume":"115","author":"TY Kim","year":"2005","unstructured":"Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope. 2005;115:1074\u20138.","journal-title":"Laryngoscope."},{"key":"950_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00003072-200103000-00002","volume":"26","author":"CD Ramos","year":"2001","unstructured":"Ramos CD, Chisin R, Yeung HW, Larson SM, Macapinlac HA. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med. 2001;26:193\u20137.","journal-title":"Clin Nucl Med."},{"key":"950_CR16","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1210\/jcem.87.4.8371","volume":"87","author":"A Bruel Van den","year":"2002","unstructured":"Van den Bruel A, Maes A, De Potter T, Mortelmans L, Drijkoningen M, Van Damme B, et al. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab. 2002; 87:1517\u201320.","journal-title":"J Clin Endocrinol Metab."},{"key":"950_CR17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiol.2361041007","volume":"236","author":"JG Yi","year":"2005","unstructured":"Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, et al. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET\/CT for non-small cell lung cancer. Radiology. 2005;236:271\u20135.","journal-title":"Radiology."},{"key":"950_CR18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2214\/ajr.183.4.1831143","volume":"183","author":"N Pandit-Taskar","year":"2004","unstructured":"Pandit-Taskar N, Schoder H, Gonen M, Larson SM, Yeung HW. Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET. AJR Am J Roentgenol. 2004;183:1143\u20137.","journal-title":"AJR Am J Roentgenol."},{"key":"950_CR19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1148\/radiol.2493080240","volume":"249","author":"B Krug","year":"2008","unstructured":"Krug B, Crott R, Lonneux M, Baurain JF, Pirson AS, Vander Borght T. Role of PET in the initial staging of cutaneous malignant melanoma: systematic review. Radiology. 2008;249:836\u201344.","journal-title":"Radiology."},{"key":"950_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rcl.2004.09.001","volume":"43","author":"A Mavi","year":"2005","unstructured":"Mavi A, Lakhani P, Zhuang H, Gupta NC, Alavi A. Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer. Radiol Clin North Am. 2005;43:1\u201321, ix.","journal-title":"Radiol Clin North Am."},{"key":"950_CR21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.bjc.6601561","volume":"90","author":"R Naumann","year":"2004","unstructured":"Naumann R, Beuthien-Baumann B, Reiss A, Schulze J, H\u00e4nel A, Bredow J, et al. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin\u2019s lymphoma. Br J Cancer. 2004;90:620\u20135.","journal-title":"Br J Cancer."},{"key":"950_CR22","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1200\/JCO.2004.01.083","volume":"22","author":"HL Westreenen van","year":"2004","unstructured":"van Westreenen HL, Westerterp M, Bossuyt PM, Pruim J, Sloof GW, van Lanschot JJ, et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004;22:3805\u201312.","journal-title":"J Clin Oncol."},{"key":"950_CR23","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.1996.14.6.1848","volume":"14","author":"N Avril","year":"1996","unstructured":"Avril N, Dose J, Janicke F, Bense S, Ziegler S, Laubenbacher C, et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. J Clin Oncol. 1996;14:1848\u201357.","journal-title":"J Clin Oncol."},{"key":"950_CR24","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1002\/1097-0142(19930615)71:12<3920::AID-CNCR2820711220>3.0.CO;2-N","volume":"71","author":"OE Nieweg","year":"1993","unstructured":"Nieweg OE, Kim EE, Wong WH, Broussard WF, Singletary SE, Hortobagyi GN, et al. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer. 1993;71:3920\u20135.","journal-title":"Cancer."},{"key":"950_CR25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1148\/radiology.179.3.2027989","volume":"179","author":"RL Wahl","year":"1991","unstructured":"Wahl RL, Cody RL, Hutchins GD, Mudgett EE. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1991;179:765\u201370.","journal-title":"Radiology."},{"key":"950_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10549-004-3291-7","volume":"90","author":"CR Isasi","year":"2005","unstructured":"Isasi CR, Moadel RM, Blaufox MD. A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat. 2005;90:105\u201312.","journal-title":"Breast Cancer Res Treat."},{"key":"950_CR27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1245\/ASO.2006.03.035","volume":"13","author":"ER Port","year":"2006","unstructured":"Port ER, Yeung H, Gonen M, Liberman L, Caravelli J, Borgen P, et al. 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma. Ann Surg Oncol. 2006;13:677\u201384.","journal-title":"Ann Surg Oncol."},{"key":"950_CR28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/MNM.0b013e3282f8147a","volume":"29","author":"S Basu","year":"2008","unstructured":"Basu S, Houseni M, Alavi A. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management. Nucl Med Commun. 2008;29:367\u201373.","journal-title":"Nucl Med Commun."},{"key":"950_CR29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiology.187.3.8497624","volume":"187","author":"LP Adler","year":"1993","unstructured":"Adler LP, Crowe JP, al-Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology. 1993;187:743\u201350.","journal-title":"Radiology."},{"key":"950_CR30","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","volume":"18","author":"N Avril","year":"2000","unstructured":"Avril N, Rose CA, Schelling M, Dose J, Kuhn W, Bense S, et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol. 2000;18:3495\u2013502.","journal-title":"J Clin Oncol."},{"key":"950_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000658-199207000-00005","volume":"216","author":"NY Tse","year":"1992","unstructured":"Tse NY, Hoh CK, Hawkins RA, Zinner MJ, Dahlbom M, Choi Y, et al. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg. 1992;216:27\u201334.","journal-title":"Ann Surg."},{"key":"950_CR32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000658-200211000-00012","volume":"236","author":"JJ Hoeven van der","year":"2002","unstructured":"van der Hoeven JJ, Hoekstra OS, Comans EF, Pijpers R, Boom RP, van Geldere D, et al. Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Ann Surg. 2002;236:619\u201324.","journal-title":"Ann Surg."},{"key":"950_CR33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.rcl.2007.05.004","volume":"45","author":"N Avril","year":"2007","unstructured":"Avril N, Adler LP. F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging. Radiol Clin North Am. 2007;45:645\u201357, vi.","journal-title":"Radiol Clin North Am."},{"key":"950_CR34","first-page":"61","volume":"50","author":"JF Santiago","year":"2006","unstructured":"Santiago JF, Gonen M, Yeung H, Macapinlac H, Larson S. A retrospective analysis of the impact of 18F-FDG PET scans on clinical management of 133 breast cancer patients. Q J Nucl Med Mol Imaging. 2006;50:61\u20137.","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"950_CR35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdl425","volume":"18","author":"U Veronesi","year":"2007","unstructured":"Veronesi U, De Cicco C, Galimberti VE, Fernandez JR, Rotmensz N, Viale G, et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol. 2007;18:473\u20138.","journal-title":"Ann Oncol."},{"key":"950_CR36","first-page":"145","volume":"33","author":"MM Abouzied","year":"2005","unstructured":"Abouzied MM, Crawford ES, Nabi HA. 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol. 2005;33:145\u201355; quiz 162\u20133.","journal-title":"J Nucl Med Technol."},{"key":"950_CR37","first-page":"170","volume":"44","author":"C Cohade","year":"2003","unstructured":"Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat (\u201cUSA-Fat\u201d): description on 18F-FDG PET\/CT. J Nucl Med. 2003;44:170\u20136.","journal-title":"J Nucl Med."},{"key":"950_CR38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0001-2998(96)80006-7","volume":"26","author":"GJ Cook","year":"1996","unstructured":"Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308\u201314.","journal-title":"Semin Nucl Med."},{"key":"950_CR39","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2214\/ajr.169.6.9393189","volume":"169","author":"BA Gordon","year":"1997","unstructured":"Gordon BA, Flanagan FL, Dehdashti F. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. AJR Am J Roentgenol. 1997;169:1675\u201380.","journal-title":"AJR Am J Roentgenol."},{"key":"950_CR40","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00259-002-0902-6","volume":"29","author":"TF Hany","year":"2002","unstructured":"Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schultess GK. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging. 2002;29:1393\u20138.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"950_CR41","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1148\/rg.245035725","volume":"24","author":"L Kostakoglu","year":"2004","unstructured":"Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics. 2004; 24:1411\u201331.","journal-title":"Radiographics."},{"key":"950_CR42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1148\/radiographics.19.1.g99ja0761","volume":"19","author":"PD Shreve","year":"1999","unstructured":"Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61\u201377; quiz 150\u201351.","journal-title":"Radiographics."},{"key":"950_CR43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11307-006-0060-5","volume":"8","author":"R Kumar","year":"2006","unstructured":"Kumar R, Chauhan A, Zhuang H, Chandra P, Schnall M, Alavi A. Standardized uptake values of normal breast tissue with 2-deoxy-2-[F-18]fluoro-D: -glucose positron emission tomography: variations with age, breast density, and menopausal status. Mol Imaging Biol. 2006;8:355\u201362.","journal-title":"Mol Imaging Biol."},{"key":"950_CR44","first-page":"1238","volume":"44","author":"D Vranjesevic","year":"2003","unstructured":"Vranjesevic D, Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, et al. Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. J Nucl Med. 2003;44:1238\u201342.","journal-title":"J Nucl Med."},{"key":"950_CR45","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.acra.2007.03.010","volume":"14","author":"CY Lin","year":"2007","unstructured":"Lin CY, Ding HJ, Liu CS, Chen YK, Lin CC, Kao CH. Correlation between the intensity of breast FDG uptake and menstrual cycle. Acad Radiol. 2007;14:940\u20134.","journal-title":"Acad Radiol."},{"key":"950_CR46","first-page":"1186","volume":"38","author":"N Avril","year":"1997","unstructured":"Avril N, Bense S, Ziegler SI, Dose J, Weber W, Laubenbacher C, et al. Breast imaging with fluorine-18-FDG PET: quantitative image analysis. J Nucl Med. 1997;38:1186\u201391.","journal-title":"J Nucl Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-010-0950-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-010-0950-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-010-0950-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T22:42:43Z","timestamp":1634942563000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-010-0950-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,17]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1245\/s10434-010-0950-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,17]]}}}